Company facts
- Industry
- Pharmaceutical Preparations
- Headquarters
- Miami, Florida
- Most recent report
- 10-Q, filed Aug 14, 2026
- Incorporated
- Florida
- Filings on record
- 140 filings
- On EDGAR
- CIK 1695473
- Fiscal year ends
- December
- Filer status
- Non-accelerated filer Smaller reporting company
Financials 8 of 42
News 8 of 28
Prospectuses and Registrations 8 of 11
- S-1/A Registration statement for an offering, amended Jun 14, 2021
- S-1 Registration statement for an offering May 7, 2021
- S-1/A Registration statement for an offering, amended Jul 16, 2020
- S-1 Registration statement for an offering Jul 8, 2020
- S-1/A Registration statement for an offering, amended Feb 10, 2020
- S-1 Registration statement for an offering Jan 16, 2020
- POS AM Post-effective amendment to a registration Jun 27, 2018
- S-1/A Registration statement for an offering, amended Aug 25, 2017
Proxies 1
Ownership 8
- SCHEDULE 13D Large holder reported an active stake Jul 16, 2026
- 3 Insider reported their initial holding Jul 16, 2026
- 3 Insider reported their initial holding Jul 16, 2026
- 3 Insider reported their initial holding Apr 10, 2025
- 4 Insider reported a trade Apr 8, 2025
- 4 Insider reported a trade Dec 4, 2019
- 4 Insider reported a trade Nov 29, 2019
- 3 Insider reported their initial holding Jan 23, 2019
Other 8 of 50
Everything here comes from Trafalgar International, Inc.'s own filings on SEC EDGAR. The filing list is rechecked every hour.